Carmell Therapeutics (CTCX)
NASDAQ:CTCX
US Market
Holding CTCX?
Track your performance easily

Carmell Therapeutics (CTCX) Ownership - Who Owns Carmell Therapeutics?

19 Followers

Carmell Therapeutics (CTCX) Ownership Overview

56.17%1.29%10.39%32.15%
56.17% Insiders
10.39% Other Institutional Investors
32.15% Public Companies and
Individual Investors
The ownership structure of Carmell Therapeutics (CTCX) stock is a mix of institutional, retail and individual investors. Approximately 11.68% of the company’s stock is owned by Institutional Investors, 56.17% is owned by Insiders and 32.15% is owned by Public Companies and Individual Investors.
The ownership structure of Carmell Therapeutics (CTCX) stock is a mix of institutional, retail and individual investors. Approximately 11.68% of the company’s stock is owned by Institutional Investors, 56.17% is owned by Insiders and 32.15% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 16, 2024
xxxxxxxxxxxxx
$2300
Sep 10, 2024
xxxxxxxxxxxxx
$643
Sep 10, 2024
xxxxxxxxxxxxx
$515
Sep 10, 2024
xxxxxxxxxxxxx
$219

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
179,591Institution0.86%55,673
179,591Institution0.86%55,673
87,988Institution0.42%27,276
29,800Institution0.14%9,238
1,749Institution<0.01%542

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
179,591Institution0.86%55,673
87,988Institution0.42%27,276
1,749Institution<0.01%542

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
168,369Institution0.81%107,419
29,800Institution0.14%9,539
11,222Institution0.05%7,160

FAQ

Who Owns Carmell Therapeutics (CTCX)?
According to the latest TipRanks data, approximately 10.39% of the company's stock is held by institutional investors, 56.17% is held by insiders, and 32.15% is held by retail investors.
    What percentage of Carmell Therapeutics (CTCX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 10.39% of Carmell Therapeutics (CTCX) stock is held by institutional investors.
      What percentage of Carmell Therapeutics (CTCX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 32.15% of Carmell Therapeutics (CTCX) stock is held by retail investors.
        Who owns the most shares of Carmell Therapeutics (CTCX)?
        Vanguard owns the most shares of Carmell Therapeutics (CTCX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis